MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological Outcomes.
Chagas disease is caused by the parasite Trypanosoma cruzi, and it begins with a short acute phase characterized by high parasitemia followed by a life-long chronic phase with scarce parasitism. Cardiac involvement is the most prominent manifestation, as 30% of infected subjects will develop abnormal ventricular repolarization with myocarditis, fibrosis and cardiomyocyte hypertrophy by undefined mechanisms. Nevertheless, follow-up studies in chagasic patients, as well as studies with murine models, suggest that the intensity of clinical symptoms and pathophysiological events that occur during the acute phase of disease are associated with the severity of cardiac disease observed during the chronic phase. In the present study we investigated the role of microRNAs (miRNAs) in the disease progression in response to T. cruzi infection, as alterations in miRNA levels are known to be associated with many cardiovascular disorders. We screened 641 rodent miRNAs in heart samples of mice during an acute infection with the Colombiana T.cruzi strain and identified multiple miRNAs significantly altered upon infection. Seventeen miRNAs were found significantly deregulated in all three analyzed time points post infection. Among these, six miRNAs had their expression correlated with clinical parameters relevant to the disease, such as parasitemia and maximal heart rate-corrected QT (QTc) interval. Computational analyses identified that the gene targets for these six miRNAs were involved in networks and signaling pathways related to increased ventricular depolarization and repolarization times, important factors for QTc interval prolongation. The data presented here will guide further studies about the contribution of microRNAs to Chagas heart disease pathogenesis.
Authors
Isabela Cunha Navarro; Frederico Moraes Ferreira; Helder I Nakaya; Monique Andrade Baron; Gláucia Vilar-Pereira; Isabela Resende Pereira; Ana Maria Gonçalves Silva; Juliana Monte Real; Thales De Brito; Christophe Chevillard; Joseli Lannes-Vieira; Jorge Kalil; Edecio Cunha-Neto; Ludmila Rodrigues Pinto Ferreira
External link
Publication Year
Publication Journal
Associeted Project
Integrative Biology
Lista de serviços
-
Systems vaccinology: its promise and challenge for HIV vaccine development.Systems vaccinology: its promise and challenge for HIV vaccine development.
-
Systems vaccinology: learning to compute the behavior of vaccine induced immunity.Systems vaccinology: learning to compute the behavior of vaccine induced immunity.
-
Systems biology of vaccination in the elderly.Systems biology of vaccination in the elderly.
-
Immunity to viruses: learning from successful human vaccines.Immunity to viruses: learning from successful human vaccines.
-
Systems biological approaches to measure and understand vaccine immunity in humans.Systems biological approaches to measure and understand vaccine immunity in humans.
-
Gene signatures related to B-cell proliferation predict influenza vaccine-induced antibody response.Gene signatures related to B-cell proliferation predict influenza vaccine-induced antibody response.
-
Vaccinology in the era of high-throughput biology.Vaccinology in the era of high-throughput biology.
-
Systems vaccinology: Enabling rational vaccine design with systems biological approaches.Systems vaccinology: Enabling rational vaccine design with systems biological approaches.
-
Systems Vaccinology Applied to DNA Vaccines: Perspective and Challenges.Systems Vaccinology Applied to DNA Vaccines: Perspective and Challenges.
-
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
-
Methods for predicting vaccine immunogenicity and reactogenicity.Methods for predicting vaccine immunogenicity and reactogenicity.
-
Antigenicity prediction and vaccine recommendation of human influenza virus A (H3N2) using convolutional neural networks.Antigenicity prediction and vaccine recommendation of human influenza virus A (H3N2) using convolutional neural networks.
-
Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine.Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine.
-
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine.Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine.
-
Induction of Cell Cycle and NK Cell Responses by Live-Attenuated Oral Vaccines against Typhoid Fever.Induction of Cell Cycle and NK Cell Responses by Live-Attenuated Oral Vaccines against Typhoid Fever.
-
Systems Biology Analysis of the Radiation-Attenuated Schistosome Vaccine Reveals a Role for Growth Factors in Protection and Hemostasis Inhibition in Parasite Survival.Systems Biology Analysis of the Radiation-Attenuated Schistosome Vaccine Reveals a Role for Growth Factors in Protection and Hemostasis Inhibition in Parasite Survival.
-
Molecular alterations in human milk in simulated maternal nasal mucosal infection with live attenuated influenza vaccinationMolecular alterations in human milk in simulated maternal nasal mucosal infection with live attenuated influenza vaccination
-
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.
-
Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.
-
Systems vaccinology.Systems vaccinology.
-
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.
-
Systems biology of vaccination for seasonal influenza in humans.Systems biology of vaccination for seasonal influenza in humans.
-
Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in childrenPrior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children
-
Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.
-
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.
-
Long noncoding RNAs are involved in multiple immunological pathways in response to vaccination.Long noncoding RNAs are involved in multiple immunological pathways in response to vaccination.
-
Metabolic Phenotypes of Response to Vaccination in Humans.Metabolic Phenotypes of Response to Vaccination in Humans.
-
Hidden in plain sight: uncovering the role of CREB1 in HIV-1 vaccine-induced immunityHidden in plain sight: uncovering the role of CREB1 in HIV-1 vaccine-induced immunity
-
Transcriptomic signatures induced by the Ebola virus vaccine rVSV-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker studyTranscriptomic signatures induced by the Ebola virus vaccine rVSV-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study
-
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohortsBaseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts
-
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GPGlobal blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP